Home » Technology Transfer and Consultancy & Scientific Services » Technologies Available for Transfer » A Rapid, Continuous and Renewable Method for Multiplication Of Ophiorrhiza rugosa as a Source of Anti-Cancer Drug Camptothecin
RSS Feed
A Rapid, Continuous and Renewable Method for
Multiplication Of Ophiorrhiza rugosa as a Source of Anti-Cancer Drug Camptothecin
  • Overview
  • Quick View Leaflet
  • Detail Technical Brochure
  • Application Procedure
A Rapid, Continuous and Renewable Method for Multiplication Of <em> Ophiorrhiza rugosa</em> as a Source of Anti-Cancer Drug Camptothecin

 

 

Overview

Anticancer drug Camptothecin

Medicinal plants form an important source for a wide variety of natural products used in the treatment of a various types of diseases like cancer, hypertension, malaria, AIDS etc. These drugs possess a complex organic structure with several chiral centres and are difficult to synthesise in the laboratory. On the contrary, plants accumulate these products with ease under natural conditions. This in turn has resulted in the exploitation of several medicinal plants for the production and export of life saving drugs. In the case of the anticancer drug camptothecin, commercial production is from Camptotheca acuminata & Nothapodytes foetida. Many trees are uprooted from the natural flora and used for camptothecin production. BARC has developed a rapid, continuous and renewable method for multiplication of Ophiorrhiza rugosa as a sustainable source of anti-cancer drug camptothecin.

A Rapid, Continuous and Renewable Method for Multiplication Of <em> Ophiorrhiza rugosa</em> as a Source of Anti-Cancer Drug Camptothecin

Anticancer drug Camptothecin

Quick View Leaflet

Medicinal plants form an important source for a wide variety of natural products used in the treatment of a various types of diseases like cancer, hypertension, malaria, AIDS etc. These drugs possess a complex organic structure with several chiral centres and are difficult to synthesise in the laboratory. On the contrary, plants accumulate these products with ease under natural conditions. This in turn has resulted in the exploitation of several medicinal plants for the production and export of life saving drugs. In the case of the anticancer drug camptothecin, commercial production is from Camptotheca acuminata & Nothapodytes foetida. Many trees are uprooted from the natural flora and used for camptothecin production. BARC has developed a technology for micropropagation of Ophiorrhiza rugosa which offers a continuous source of numerous uniform size plants throughout the year.

 SALIENT FEATURES

  • Rapid multiplication of uniform or true type plants.

  • Requirement of limited number of explant.

  • Disease free planting material.

  • Plants in nature, survive only for 8-9 months whereas the present technology represents a continuous and a reproducible method for mass multiplication of Ophiorrhiza rugosa as a sustainable source of anti-cancer drug Camptothecin.

APPLICATIONS

  • Agriculture sector.

  • Biotechnology and pharmaceutical companies.

  • Plant nurseries.

A Rapid, Continuous and Renewable Method for Multiplication Of <em> Ophiorrhiza rugosa</em> as a Source of Anti-Cancer Drug Camptothecin
Detail Technical Brochure

Anticancer drug Camptothecin

Medicinal plants form an important source for a wide variety of natural products used in the treatment of a various types of diseases like cancer, hypertension, malaria, AIDS etc. These drugs possess a complex organic structure with several chiral centres and are difficult to synthesise in the laboratory. On the contrary, plants accumulate these products with ease under natural conditions. This in turn has resulted in the exploitation of several medicinal plants for the production and export of life saving drugs. In the case of the anticancer drug camptothecin, commercial production is from Camptotheca acuminata and Nothapodytes foetida. Many trees are uprooted from the natural flora and used for camptothecin production. BARC has developed a rapid, continuous and renewable method for multiplication of Ophiorrhiza rugosa as a sustainable source of anti-cancer drug camptothecin.

ADVANTAGES

  • The method is reproducible.
  • High levels of camptothecin can be obtained during a short period of time.
  • Plants, in nature survive only for 8-9 months whereas the present technology represents a continuous and a reproducible method for multiplication of Ophiorrhiza rugosa.

APPLICATIONS

  • The method is useful to multiply elite medicinal plants which in turn help in the conservation and preservation of endangered medicinal plants that are becoming rare and extinct in the natural habitat due to overexploitation.
  • This technology can be taken up by biotech and pharmaceutical companies already engaged in medicinal plant based research.

INFRASTRUCTURE REQUIREMENT

a. Raw Material

  • Plant parts of Ophiorrhiza rugosa.
  • Chemicals: MS medium and hormones used in this protocol is available locally.

b. Equipments

  • Autoclave
  • Laminar air-flow unit
  • Water distillation unit
  • pH meter
  • Analytical balance
  • Refrigerator
  • Standard laboratory glasswares

c. Space

  • Standard tissue culture laboratory: A small room of 400 sq. ft. area (20 ft x 20 ft) with routine tissue culture facilities.
  • Culture room (100 sqft): clean, air conditioned and well illuminated room to grow the cultures.

Power

  • Both single & three phase power connection.

Manpower

  • Two skilled technicians for preparing medium and tissue culture work.

Who Should apply


Interested parties with Engineering & Scientific knowledge, good financial background and adequate experience of products manufacturing & fabrication with technical capability in the area of interested technology and having or interested in setting –up facilities for production would be preferred.


How to apply

Send your Technology Transfer Application form duly filled and signed alongwith a Demand Draft/Bankers cheque of Rs. 500/- (for Indian entities) or US $50/- (for foreign entities) drawn in favour of “Accounts Officer, BARC” as application processing fee on following address: 

Head, Technology Transfer and Collaboration Division 
Bhabha Atomic Research Centre,
Trombay, Mumbai – 400 085, India.

Fax : +91-22-25505151


Note:Applications without processing fee as applicable above of Rs. 500/- or US $50/- for each technology will not be considered.


Click here for Technology Transfer Application Form

Contact Us

Head, 
Technology Transfer and Collaboration Division
Bhabha Atomic Research Centre,
Trombay, Mumbai 400 085.

Fax : +91-22- 25505151
Email : technology@barc.gov.in

How to apply

BACK
 
Top Close